Targeting the EGF Receptor for Ovarian Cancer Therapy

Table 3

Clinical trials combining the EGF receptor antagonists with other signaling pathway inhibitors.

---

American Society of Clinical Oncology (ASCO) 2009 Annual Meeting Proceedings

---

Phase I trial of bevacizumab + everolimus + panitumumab in refractory solid tumors [117]

Phase I trial of cetuximab and erlotinib in solid tumors [119]

Phase I trial of dasatinib + cetuximab in advanced solid tumors [120]

---